Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Cancer Survivorship
Erschienen in: Journal of Cancer Survivorship 3/2013

01.09.2013 | Review

Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies

verfasst von: Sébastien Simard, Belinda Thewes, Gerry Humphris, Mélanie Dixon, Ceara Hayden, Shab Mireskandari, Gozde Ozakinci

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Fear of cancer recurrence (FCR) is among the most commonly reported problems and one of the most prevalent areas of unmet needs for cancer survivors and their carers. This review aims to provide a comprehensive overview of current scientific knowledge on FCR and to formulate recommendations for future research.

Methods

A systematic review was undertaken to identify quantitative studies associated with FCR. Relevant studies were identified via Medline, CINAHL, PsycINFO and AMED databases from 1996 through December 2011. Data from 130 eligible papers were extracted and summarized following a systematic scheme.

Results

Multiple FCR assessment methods were identified. Survivors reported low to moderate level of FCR but considered it as one of the top greatest concerns and the most frequently endorsed unmet need. FCR remains stable over the survivorship trajectory. Younger age, presence and severity of physical symptoms, psychological distress and lower quality of life were associated with higher FCR. Health behaviours, psychological reactions and functional impairments were identified as FCR consequences. Carers reported higher FCR than the patients. Limited data on interventions were available.

Conclusions

FCR research has expanded somewhat haphazardly over the last 20 years. Adopted consensual definition and used well-validated measures will be necessary. Longitudinal research examining the longer-term development and impact of FCR is clearly needed. The proposal and evaluation of theoretical models of FCR is a priority.

Implications for Cancer Survivors

Identifying the key features of FCR will stimulate the research and the development of targeted interventions for cancer survivors and their carers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington: National Academies Press; 2006.
2.
Baker F, Denniston M, Smith T, et al. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Suppl):2565–76.PubMedCrossRef
3.
Armes J, Crowe M, Colbourne L, et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27(36):6172–9.PubMedCrossRef
4.
Hodges LJ, Humphris GM. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psychooncology. 2009;18(8):841–8.PubMedCrossRef
5.
Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long term (≥5 years) cancer survivors: a systematic review of quantitative studies. Psychooncology. 2012. doi:10.​1002/​pon.​3022.
6.
Simard S, Savard J, Ivers H. Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv. 2010;4(4):361–71.PubMedCrossRef
7.
Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25(1):16–24.PubMedCrossRef
8.
Thewes B, Butow P, Zachariae R, et al. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21(6):571–87.PubMedCrossRef
9.
Lee-Jones C, Humphris G, Dixon R, et al. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6(2):95–105.PubMedCrossRef
10.
Leventhal H, Meyer D, Nerentz DR. The common sense representation of illness danger. In: Rachman S, editor. Contributions to medical psychology. Oxford: Pergamon; 1980. p. 7–30.
11.
Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2012. doi:10.​1002/​pon.​3114.
12.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.PubMedCrossRef
13.
Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.PubMedCrossRef
14.
Avis NE, Smith KW, McGraw S, et al. Assessing quality of life in adult cancer survivors (QLACS). Qual Life Res. 2005;14:1007–23.PubMedCrossRef
15.
Lengacher CA, Johnson-Mallard V, Post-White J, et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psychooncology. 2009;18(12):1261–72.PubMedCrossRef
16.
Parsaie FA, Golchin M, Asvadi I. A comparison of nurse and patient perceptions of chemotherapy treatment stressors. Cancer Nurs. 2000;23(5):371–4.PubMedCrossRef
17.
Hawkins NA, Smith T, Zhao L, et al. Health-related behavior change after cancer: results of the American Cancer Society’s studies of cancer survivors (SCS). J Cancer Surviv. 2010;4(1):20–32.PubMedCrossRef
18.
Lengacher CA, Johnson-Mallard V, Barta M, et al. Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs. 2011;29(2):107–17.PubMedCrossRef
19.
Shields CG, Ziner KW, Bourff SA, et al. An intervention to improve communication between breast cancer survivors and their physicians. J Psychoso Oncol. 2010;28(6):610–29.CrossRef
20.
Befort CA, Austin H, Klemp JR. Weight control needs and experiences among rural breast cancer survivors. Psychooncology. 2011;20(10):1069–75.PubMedCrossRef
21.
Gore JL, Gollapudi K, Bergman J, et al. Correlates of bother following treatment for clinically localized prostate cancer. J Urol. 2010;184(4):1309–15.PubMedCrossRef
22.
Deimling GT, Wagner LJ, Bowman KF, et al. Coping among older-adult, long-term cancer survivors. Psychooncology. 2006;15(2):143–59.PubMedCrossRef
23.
Humphris GM, Rogers SN. The association of cigarette smoking and anxiety, depression and fears of recurrence in patients following treatment of oral and oropharyngeal malignancy. Eur J Cancer Care. 2004;13(4):328–35.CrossRef
24.
Mellon S, Kershaw TS, Northouse LL, et al. A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psychooncology. 2007;16(3):214–23.PubMedCrossRef
25.
Mellon S, Northouse LL, Weiss LK. A population-based study of the quality of life of cancer survivors and their family caregivers. Cancer Nurs. 2006;29(2):120–31.PubMedCrossRef
26.
Mirabeau-Beale KL, Kornblith AB, Penson RT, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009;114(2):353–9.PubMedCrossRef
27.
Sabariego C, Brach M, Herschbach P, et al. Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients. Eur J Health Econ. 2011;12(5):489–97.PubMedCrossRef
28.
Rogers SN, Scott B, Lowe D, et al. Fear of recurrence following head and neck cancer in the outpatient clinic. Eur Arch Otorhinolaryngol. 2010;267(12):1943–9.PubMedCrossRef
29.
Vickberg SMJ. Locating breast cancer in the context of women’s lives. J Psychosoc Oncol. 2003;21(2):69–88.CrossRef
30.
Fitch MI, Gray RE, Franssen E. Perspectives on living with ovarian cancer: older women’s views. Oncol Nurs Forum. 2001;28(9):1433–42.PubMed
31.
Schlairet MC. Needs of older cancer survivors in a community cancer care setting. J Gerontol Nurs. 2011;37(1):36–41.PubMedCrossRef
32.
Greenberg DB, Kornblith AB, Herndon JE, et al. Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971–1988: predictors for later psychologic distress. Cancer. 1997;80(10):1936–44.PubMedCrossRef
33.
Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51.PubMedCrossRef
34.
Herschbach P, Berg P, Dankert A, et al. Fear of progression in chronic diseases—psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res. 2005;58(6):505–11.PubMedCrossRef
35.
Costanzo ES, Lutgendorf SK, Mattes ML, et al. Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer. 2007;97(12):1625–31.PubMedCrossRef
36.
Lebel S, Rosberger Z, Edgar L, et al. Comparison of four common stressors across the breast cancer trajectory. J Psychosom Res. 2007;63(3):225–32.PubMedCrossRef
37.
Hong YM, Hu JC, Paciorek AT, et al. Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE (TM). Urol Oncol. 2010;28(3):268–73.PubMedCrossRef
38.
Essers BAB, Nieman FHM, Prins MH, et al. Determinants of satisfaction with the health state of the facial skin in patients undergoing surgery for facial basal cell carcinoma. Patient Educ Couns. 2006;60(2):179–86.PubMedCrossRef
39.
Humphris GM, Rogers S, McNally D, et al. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Inter J Oral Maxillofac Surg. 2003;32(5):486–91.
40.
Kornblith AB, Powell M, Regan MM, et al. Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007;16(10):895–903.PubMedCrossRef
41.
Stanton AL, Danoff-Burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psychooncology. 2002;11(2):93–102.PubMedCrossRef
42.
Bergman J, Gore JL, Saigal CS, et al. Partnership and outcomes in men with prostate cancer. Cancer. 2009;115(20):4688–94.PubMedCrossRef
43.
Kruger A, Leibbrand B, Barth J, et al. Course of psychosocial distress and health-related quality of life in patients at different age groups during cancer rehabilitation. Z Psychosom Med Psychother. 2009;55(2):141–61.PubMed
44.
Poulakis V, Witzsch U, de Vries R, et al. Quality of life after surgery for localized renal cell carcinoma: comparison between radical nephrectomy and nephron-sparing surgery. Urology. 2003;62(5):814–20.PubMedCrossRef
45.
Mehta SS, Lubeck DP, Pasta DJ, et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol. 2003;170(5):1931–3.PubMedCrossRef
46.
Llewellyn CD, Weinman J, McGurk M, et al. Can we predict which head and neck cancer survivors develop fears of recurrence? J Psychosom Res. 2008;65(6):525–32.PubMedCrossRef
47.
Melia M, Moy CS, Reynolds SM, et al. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma—5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Arch Ophthalmol. 2006;124(2):226–38.PubMedCrossRef
48.
Moyer A, Salovey P. Patient participation in treatment decision making and the psychological consequences of breast cancer surgery. Womens Health. 1998;4(2):103–16.PubMed
49.
Sheppard C, Higgins B, Wise M, et al. Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009;13(1):2–8.PubMedCrossRef
50.
Suchocka-Capuano A, Bredart A, Dolbeault S, et al. Quality of life and psychological state in patients with choroidal melanoma: longitudinal study. Bull Cancer. 2011;98(2):97–107.PubMed
51.
Bellizzi KM, Latini DM, Cowan JE, et al. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology. 2008;72(6):1269–73.PubMedCrossRef
52.
Bloom JR, Stewart SL, Chang S, et al. Then and now: quality of life of young breast cancer survivors. Psychooncology. 2004;13(3):147–60.PubMedCrossRef
53.
Lebel S, Rosberger Z, Edgar L, et al. Emotional distress impacts fear of the future among breast cancer survivors not the reverse. J Cancer Surviv. 2009;3(2):117–27.PubMedCrossRef
54.
Sollner W, Zingg-Schir M, Rumpold G, et al. Need for supportive counselling—the professionals’ versus the patients’ perspective—a survey in a representative sample of 236 melanoma patients. Psychother Psychosom. 1998;67(2):94–104.PubMedCrossRef
55.
Curran D, van Dongen JP, Aaronson NK, et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801. Eur J Cancer. 1998;34(3):307–14.PubMedCrossRef
56.
Hartl K, Janni W, Kastner R, et al. Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Ann Oncol. 2003;14(7):1064–71.PubMedCrossRef
57.
Leake RL, Gurrin LC, Hammond IG. Quality of life in patients attending a low-risk gynaecological oncology follow-up clinic. Psychooncology. 2001;10(5):428–35.PubMedCrossRef
58.
Ashing-Giwa KT, Lim JW. Examining emotional outcomes among a multiethnic cohort of breast cancer survivors. Oncol Nurs Forum. 2011;38(3):279–92.PubMedCrossRef
59.
Davey C, White V, Warne C, et al. Understanding a ductal carcinoma in situ diagnosis: patient views and surgeon descriptions. Eur J Cancer Care. 2011;20(6):776–84.CrossRef
60.
Mast ME. Survivors of breast cancer: illness uncertainty, positive reappraisal, and emotional distress. Oncol Nurs Forum. 1998;25(3):555–62.PubMed
61.
Mullens AB, McCaul KD, Erickson SC, et al. Coping after cancer: risk perceptions, worry, and health behaviors among colorectal cancer survivors. Psychooncology. 2004;13(6):367–76.PubMedCrossRef
62.
Waljee JF, Hu ES, Ubel PA, et al. Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol. 2008;26(20):3331–7.PubMedCrossRef
63.
van den Beuken-van Everdingen MHJ, Peters ML, de Rijke JM, et al. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psychooncology. 2008;17(11):1137–45.PubMedCrossRef
64.
Janz NK, Hawley ST, Mujahid MS, et al. Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer. Cancer. 2011;117(9):1827–36.PubMedCrossRef
65.
Liu Y, Perez M, Schootman M, et al. Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2011;130(1):165–73.PubMedCrossRef
66.
Diefenbach M, Mohamed NE, Horwitz E, et al. Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of age. Psychol Health Med. 2008;13(2):146–61.PubMedCrossRef
67.
Gemmill R, Sun V, Ferrell B, et al. Going with the flow quality-of-life outcomes of cancer survivors with urinary diversion. J Wound Ostomy Continence Nurs. 2010;37(1):65–72.PubMedCrossRef
68.
Roth AJ, Rosenfeld B, Kornblith AB, et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer. 2003;97(11):2910–8.PubMedCrossRef
69.
Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psychooncology. 2009;18(6):580–8.PubMedCrossRef
70.
Hamrick N, Diefenbach MA. Religion and spirituality among patients with localized prostate cancer. Palliat Support Care. 2006;4(4):345–55.PubMedCrossRef
71.
Mehnert A, Berg P, Henrich G, et al. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273–80.PubMedCrossRef
72.
Franssen SJ, Lagarde SM, van Werven JR, et al. Psychological factors and preferences for communicating prognosis in esophageal cancer patients. Psychooncology. 2009;18:1199–207.PubMedCrossRef
73.
Pandya DM, Patel S, Ketchum NS, et al. A comparison of races and leukemia subtypes among patients in different cancer survivorship phases. Clin Lymphoma Myeloma Leuk. 2011;11 Suppl 1:S114–8.PubMedCrossRef
74.
Deimling GT, Bowman KF, Sterns S, et al. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15(4):306–20.PubMedCrossRef
75.
Rabin C, Leventhal H, Goodin S. Conceptualization of disease timeline predicts posttreatment distress in breast cancer patients. Health Psychol. 2004;23(4):407–12.PubMedCrossRef
76.
Roth A, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47(4):340–7.PubMedCrossRef
77.
Bölter AF, Lange J, Anger B, et al. Who has more anxiety concerning a shortened life span: terminal cancer patients or those in curative therapy? Psychother Psychosom Med Psychol. 2010;60(7):255–61.PubMedCrossRef
78.
Shanafelt TD, Bowen DA, Venkat C, et al. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res. 2009;33(2):263–70.PubMedCrossRef
79.
Latini DM, Hart SL, Knight SJ, et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol. 2007;178(3):826–31.PubMedCrossRef
80.
Shim E, Shin Y, Oh D, et al. Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry. 2010;32(2):169–75.PubMedCrossRef
81.
Ullrich PM, Carson MR, Lutgendorf SK, et al. Cancer fear and mood disturbance after radical prostatectomy: consequences of biochemical evidence of recurrence. J Urol. 2003;169(4):1449–52.PubMedCrossRef
82.
Rosmolen WD, Boer KR, de Leeuw RJ, et al. Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barrett’s esophagus. Endoscopy. 2010;42(7):525–31.PubMedCrossRef
83.
Melia M, Moy CS, Reynolds SM, et al. Development and validation of disease-specific measures for choroidal melanoma—COMS-QOLS Report no. 2. Arch Ophthalmol. 2003;121(7):1010–20.PubMedCrossRef
84.
Sung TY, Shin YW, Nam KH, et al. Psychological impact of thyroid surgery on patients with well-differentiated papillary thyroid cancer. Qual Life Res. 2011;20(9):1411–7.PubMedCrossRef
85.
Walker BL. Adjustment of husbands and wives to breast cancer. Cancer Pract. 1997;5(2):92–8.PubMed
86.
de Haes J, Curran D, Aaronson NK, et al. Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer. 2003;39(7):945–51.PubMedCrossRef
87.
Yeo W, Kwan WH, Teo PM, et al. Psychosocial impact of breast cancer surgeries in Chinese patients and their spouses. Psychooncology. 2004;13(2):132–9.PubMedCrossRef
88.
Clark PE, Schover LR, Uzzo RG, et al. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology. 2001;57(2):252–6.PubMedCrossRef
89.
Matulonis UA, Kornblith A, Lee H, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18(6):1183–93.PubMedCrossRef
90.
Mellon S, Northouse LL. Family survivorship and quality of life following a cancer diagnosis. Res Nurs Health. 2001;24(6):446–59.PubMedCrossRef
91.
Biglia N, Cozzarella M, Cacciari F, et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas. 2003;45(1):29–38.PubMedCrossRef
92.
Befort CA, Klemp J. Sequelae of breast cancer and the influence of menopausal status at diagnosis among rural breast cancer survivors. J Womens Health. 2011;20(9):1307–13.CrossRef
93.
Montazeri A, Sajadian A, Ebrahimi M, et al. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. Eur J Cancer Care. 2006;16(2):144–9.CrossRef
94.
Burstein HJ, Gelber S, Guadagnoli E, et al. Use of alternative medicine by women with early stage breast cancer. N Engl J Med. 1999;340(22):1733–9.PubMedCrossRef
95.
Stein KD, Kaw C, Crammer C, et al. The role of psychological functioning in the use of complementary and alternative methods among disease-free colorectal cancer survivors: a report from the American Cancer Society’s studies of cancer survivors. Cancer. 2009;115(18 Suppl):4397–408.PubMedCrossRef
96.
Carpenter CL, Ganz PA, Bernstein L. Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat. 2009;116:387–96.PubMedCrossRef
97.
Steele N, Haigh R, Knowles G, et al. Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think? Postgrad Med J. 2007;83(983):612–4.PubMedCrossRef
98.
Kelly KM, Shedlosky-Shoemaker R, Porter K, et al. Cancer recurrence worry, risk perception, and informational-coping styles among Appalachian cancer survivors. J Psychosoc Oncol. 2011;29(1):1–18.PubMedCrossRef
99.
Hart SL, Latini DM, Cowan JE, et al. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008;16(2):161–9.PubMedCrossRef
100.
Gotay CC, Pagano IS. Assessment of Survivor Concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes. 2007;5(15):1–11.
101.
Engst-Hastreiter U, Duran G, Henrich G, et al. Fear of progression (FOP) in chronic diseases (rheumatic diseases, cancer and diabetes mellitus)—development of a psychological self-assessment instrument and a group therapy program. Aktuelle Rheumatol. 2004;29(2):83–91.CrossRef
102.
Waters EA, Arora NK, Klein WMP, et al. Perceived risk, trust and health-related quality of life among cancer survivors. Ann Behav Med. 2010;39(1):91–7.PubMedCrossRef
103.
Tzeng JP, Mayer D, Richman AR, et al. Women’s experiences with genomic testing for breast cancer recurrence risk. Cancer. 2010;116(8):1992–2000.PubMedCrossRef
104.
Schreiber JA. Image of God: effect on coping and psychospiritual outcomes in early breast cancer survivors. Oncol Nurs Forum. 2011;38(3):293–301.PubMedCrossRef
105.
Cannon AJ, Darrington DL, Reed EC, et al. Spirituality, patients’ worry, and follow-up health-care utilization among cancer survivors. Journal Support Oncol. 2011;9(4):141–8.CrossRef
106.
Alfano CM, McGregor BA, Kuniyuki A, et al. Psychometric evaluation of the Brief Cancer Impact Assessment among breast cancer survivors. Oncology. 2006;70(3):190–202.PubMedCrossRef
107.
Zhao L, Portier K, Stein K, et al. Exploratory factor analysis of the Cancer Problems in Living Scale: a report from the American Cancer Society’s studies of cancer survivors. J Pain Sympt Manage. 2009;37(4):676–86.CrossRef
108.
Noorda EM, van Kreij RH, Vrouenraets BC, et al. The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion. Eur J Surg Oncol. 2007;33(6):776–82.PubMedCrossRef
109.
Davison BJ, Goldenberg SL. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int. 2011;108(11):1787–93.PubMedCrossRef
110.
Mikkelsen T, Sondergaard J, Sokolowski I, et al. Cancer survivors’ rehabilitation needs in a primary health care context. Fam Pract. 2009;26(3):221–30.PubMedCrossRef
111.
Tang P-L, Chiou C-P, Lin H-S, et al. Correlates of death anxiety among Taiwanese cancer patients. Cancer Nurs. 2011;34(4):286–92.PubMedCrossRef
112.
Hu JC, Kwan L, Krupski TL, et al. Determinants of treatment regret in low-income, uninsured men with prostate cancer. Urology. 2008;72(6):1274–9.PubMedCrossRef
113.
Young KE, White CA. The prevalence and moderators of fatigue in people who have been successfully treated for cancer. J Psychosom Res. 2006;60(1):29–38.PubMedCrossRef
114.
Dempster M, McCorry NK, Brennan E, et al. Psychological distress among family carers of oesophageal cancer survivors: the role of illness cognitions and coping. Psychooncology. 2011;20(7):698–705.PubMedCrossRef
115.
Matthews BA. Role and gender differences in cancer-related distress: a comparison of survivor and caregiver self-reports. Oncol Nurs Forum. 2003;30(3):493–9.PubMedCrossRef
116.
Zimmermann T, Herschbach P, Wessarges M, et al. Fear of progression in partners of chronically ill patients. Behav Med. 2011;37(3):95–104.PubMedCrossRef
117.
Herschbach P, Book K, Dinkel A, et al. Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer. 2010;18(4):471–9.PubMedCrossRef
118.
Cameron LD, Booth RJ, Schlatter M, et al. Changes in emotion regulation and psychological adjustment following use of a group psychosocial support program for women recently diagnosed with breast cancer. Psychooncology. 2007;16(3):171–80.PubMedCrossRef
119.
Simard S, Savard J. Screening and comorbidity of clinical fear of cancer recurrence. Ann Behav Med. 2009;37(Supplement):S50.
120.
Humphris G, Ozakind G. The AFTER intervention: a structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. Br J of Health Psychol. 2008;13:223–30.CrossRef
121.
Brandberg Y, Damato B, Kivela T, et al. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III). Eye. 2004;18(3):283–9.PubMedCrossRef
122.
Tilkorn M, Mawick R, Sommerfeld S, et al. Quality of life of patients with malignant facial and skin tumors—development of a questionnaire and initial findings of a study. Rehabilitation. 1990;29(2):134–9.PubMed
123.
Bartelink H, van Dam F, van Dongen J. Psychological effects of breast conserving therapy in comparison with radical mastectomy. Int J Radiat Oncol Biol Phys. 1985;11(2):381–5.PubMedCrossRef
124.
Ganz PA, Greendale GA, Petersen L, et al. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21(22):4184–93.PubMedCrossRef
125.
Easterling DV, Leventhal H. Contribution of concrete cognition to emotion: neutral symptoms as elicitors of worry about cancer. J Appl Psychol. 1989;74(5):787–96.PubMedCrossRef
126.
Lerman C, Trock B, Rimer BK, et al. Psychological side effects of breast cancer screening. Health Psychol. 1991;10(4):259–67.PubMedCrossRef
127.
Noguchi M, Kitagawa H, Kinoshita K, et al. Psychologic and cosmetic self-assessments of breast conserving therapy compared with mastectomy and immediate breast reconstruction. J Surg Oncol. 1993;54(4):260–6.PubMedCrossRef
128.
Northouse LL. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs. 1981;4(3):213–20.PubMedCrossRef
129.
Krishnan L, Stanton AL, Collins CA, et al. Form or function? Part 2. Objective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer. 2001;91(12):2282–7.PubMedCrossRef
130.
Mohan R, Beydoun H, Davis J, et al. Feasibility of using guidelines to choose treatment for prostate cancer. Can J Urol. 2010;17(1):4975–84.PubMed
131.
Stewart DE, Duff S, Wong F, et al. The views of ovarian cancer survivors on its cause, prevention, and recurrence. Medscape Womens Health. 2001;6(5):1–5.
132.
Rogers SN, El-Sheikha J, Lowe D. The development of a Patients Concerns Inventory (PCI) to help reveal patients concerns in the head and neck clinic. Oral Oncol. 2009;45(7):555–61.PubMedCrossRef
133.
Dow KH, Ferrell BR, Leigh S, et al. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat. 1996;39(3):261–73.PubMedCrossRef
134.
Spencer SM, Lehman JM, Wynings C, et al. Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients. Health Psychol. 1999;18(2):159–68.PubMedCrossRef
135.
Saleh US, Brockopp DY. Quality of life one year following bone marrow transplantation: psychometric evaluation of the quality of life in bone marrow transplant survivors tool. Oncol Nurs Forum. 2001;28(9):1457–64.PubMed
136.
Fitch MI, Gray RE, DePetrillo D, et al. Canadian women’s perspectives on ovarian cancer. Cancer Prev Control. 1999;3(1):52–60.PubMed
137.
Schlairet M, Heddon MA, Griffis M. Piloting a needs assessment to guide development of a survivorship program for a community cancer center. Oncol Nurs Forum. 2010;37(4):501–8.PubMedCrossRef
138.
Wonghongkul T, Dechaprom N, Phumivichuvate L, et al. Uncertainty appraisal coping and quality of life in breast cancer survivors. Cancer Nurs. 2006;29(3):250–7.PubMedCrossRef
139.
Ferrell BR, Grant MM, Funk BM, et al. Quality of life in breast cancer survivors: implications for developing support services. Oncol Nurs Forum. 1998;25(5):887–95.PubMed
140.
Harris K, Chow E, Zhang L, et al. Patients’ and health care professionals’ evaluation of health-related quality of life issues in bone metastases. Eur J Cancer. 2009;45(14):2510–8.PubMedCrossRef
141.
Harrison SE, Watson EK, Ward AM, et al. Primary health and supportive care needs of long-term cancer survivors: a questionnaire survey. J Clin Oncol. 2011;29(15):2091–8.PubMedCrossRef
142.
Hodgkinson K, Butow P, Fuchs A, et al. Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gynecol Oncol. 2007;104(2):381–9.PubMedCrossRef
143.
Stafford L, Judd F. Long-term quality of life in Australian women previously diagnosed with gynaecologic cancer. Support Care Cancer. 2011;19(12):2047–56.PubMedCrossRef
144.
Uchida M, Akechi T, Okuyama T, et al. Patients’ supportive care needs and psychological distress in advanced breast cancer patients in Japan. Jpn J Clin Oncol. 2011;41(4):530–6.PubMedCrossRef
145.
Katz ML, Reiter PL, Corbin S, et al. Are rural Ohio Appalachia cancer survivors needs different than urban cancer survivors? J Cancer Surviv. 2010;4(2):140–8.PubMedCrossRef
146.
McDowell ME, Occhipinti S, Ferguson M, et al. Predictors of change in unmet supportive care needs in cancer. Psychooncology. 2010;19(5):508–16.PubMedCrossRef
147.
Lobb EA, Joske D, Butow P, et al. When the safety net of treatment has been removed: patients’ unmet needs at the completion of treatment for haematological malignancies. Patient Educ Couns. 2009;77(1):103–8.PubMedCrossRef
Metadaten
Titel
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
verfasst von
Sébastien Simard
Belinda Thewes
Gerry Humphris
Mélanie Dixon
Ceara Hayden
Shab Mireskandari
Gozde Ozakinci
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2013
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-013-0272-z

Weitere Artikel der Ausgabe 3/2013

Journal of Cancer Survivorship 3/2013 Zur Ausgabe

OriginalPaper

The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability

OriginalPaper

A randomized trial of a Facebook-based physical activity intervention for young adult cancer survivors

Review

Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis

OriginalPaper

Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project

OriginalPaper

Predictors of risk-based medical follow-up: a report from the childhood cancer survivor study

OriginalPaper

Potential gonadotoxicity of treatment in relation to quality of life and mental well-being of male survivors of childhood acute lymphoblastic leukemia

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise